Healthcare Pharmaceutical Biotech

Inner Balance Review 2026: Pricing, Refund Catches, and What No Other Article Tells You About Oestra HRT

May 7, 2026 4:30 PM

Disclaimer: This article is a paid advertorial produced for informational and commercial purposes. It contains affiliate links. If a purchase is made through links in this article, a commission may be earned at no additional cost to the reader. This compensation does not influence the factual accuracy of the information presented. Medical Disclaimer: This article is for informational purposes only and does not provide medical advice, diagnosis,...

Read more

Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026

May 7, 2026 4:15 PM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today reported its financial results for the three months ended March 31, 2026. Corporate Highlights Announced agreement with FDA on a single adaptive Phase 2/3 study for approval of Gemini for treatment of acute kidney injury Received net proceeds of $6.7 million...

Read more

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026

May 7, 2026 4:05 PM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company"), a biopharmaceutical company focused on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, today reported results for the three months ended March 31, 2026. "In the first quarter of 2026, we continued to strengthen our commercial foundation and core business, highlighted by the...

Read more

IVY RX GLP-1 2026: Truth Behind the IVY RX Compounded Semaglutide Program Pricing, Flat-Rate Dosing Model, and FDA 503B Update Consumers Need Before Enrolling

May 7, 2026 2:30 PM

Advertorial Disclosure: This is sponsored advertorial content and contains affiliate links. If a purchase is made through links in this article, a commission may be earned at no additional cost to the reader. This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any prescription medication. Compounded medications have not...

Read more

Direct Meds DirectMax Review 2026: Compounded Sublingual ED Program Pricing, Ingredients, and What to Confirm With a Clinician Before You Start

May 7, 2026 2:20 PM

Advertorial Disclosure: This is an affiliate-supported advertorial. This content contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This content is for informational purposes only and does not constitute medical advice, diagnosis, or a recommendation for any specific treatment. DirectMax is a prescription-only compounded medication. Compounded medications are not FDA-approved....

Read more

JRNYS Reviewed: Truth Behind JRNYS Wellness GLP-1 Telehealth - Membership Pricing, LegitScript Certification, Three-Tier Plans, and What the 2026 FDA Compounding Update Means Before You Enroll

May 7, 2026 1:30 PM

Advertorial Disclosure: This article is an advertorial produced for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. JRNYS GLP-1 treatment options require evaluation by a licensed healthcare provider and may not be appropriate for every individual. Individual results are not guaranteed and vary based on multiple factors. Compounded medications, where discussed or prescribed, are not FDA-approved...

Read more

Eden Reviewed: 2026 Consumer Report on Try Eden GLP-1 Telehealth - In-House PCAB Pharmacy, Semaglutide From $129, and What the FDA's June 29 Deadline Means for Prospective Patients

May 7, 2026 1:20 PM

Medical Disclaimer: This advertorial is for informational purposes only and does not constitute medical advice, a treatment recommendation, or a guarantee that any prescription will be issued. Always consult a qualified, licensed healthcare professional before starting any prescription medication program. Prescription access through Eden depends on individual clinical evaluation by an independent licensed provider and is not guaranteed by...

Read more

Queue Ventures Announces Results of Special Meeting of Custom Health, Inc. in Connection With Previously Announced Plan of Arrangement

May 7, 2026 12:45 PM

Queue Ventures Ltd. ("Queue" or the "Company") is pleased to announce, further to its press release dated May 1, 2026, the results of the special meeting of shareholders ("Custom Shareholders") of Custom Health, Inc. ("Custom Health") held on May 6, 2026 (the "Custom Meeting"). Custom Shareholders voted in favour of the resolution to approve the Company's previously announced plan of arrangement (the "Arrangement") with Custom Health. As...

Read more

Medical Component Specialists Appoints Chris Hester as President and CEO to Drive Next Phase of Global Growth

May 7, 2026 12:30 PM

Medical Component Specialists, a premier provider of precision medical components, proudly announces that Chris Hester has joined the company as its President and Chief Executive Officer, effective April 27, 2026. Hester's appointment marks a pivotal milestone in the company's 2026 leadership team expansion and signals a vibrant era of forward momentum, capacity scaling, and international growth. A seasoned manufacturing leader and strategic...

Read more

BreezeMeds Reviewed: 2026 Consumer Report on Breeze Meds GLP-1 Telehealth - Semaglutide From $199, Four Named Pharmacies, and What the FDA's June 29 Deadline Means for New Patients

May 7, 2026 11:50 AM

Advertorial Disclosure: This article is a paid/affiliate informational placement. If a reader clicks a link in this article and makes a purchase through the linked page, a commission may be earned at no additional cost to the reader. This article is for informational purposes only and is not medical advice. Prescription approval is not guaranteed. Compounded GLP-1 medications are not FDA-approved finished drug products and require evaluation by...

Read more

CareBareRX Reviewed: Truth Behind Care Bare RX GLP-1 Telehealth - Pricing, Named Doctors, Licensed Pharmacies, Refund Policy, and Compounded Medication Facts Every Enrollee Needs Before Committing

May 7, 2026 11:30 AM

Advertorial Disclaimer: This is a paid advertorial produced for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. CareBareRX is a telehealth platform - not a medical provider. All healthcare services are delivered by independent licensed providers who make prescribing decisions based on their own clinical evaluation of each patient. Prescription eligibility is not guaranteed, and payment does not...

Read more

Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio

May 7, 2026 11:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that it will effect a one-for-thirty (1:30) reverse stock split (the "reverse split") of its common stock, par value $0.0001 per share (the "Common Stock"), that will become effective on May 11, 2026, at 12:01 AM Eastern Time, before the opening of trading on The Nasdaq Capital Market...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Unlocks New Applications for AI Imaging Platform in Regulated Agricultural Markets

May 7, 2026 9:15 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company"), a developer of artificial intelligence (AI) imaging solutions, today announced it is advancing new applications of its AI imaging platform focused on improving product verification and quality control in regulated agricultural markets. As regulatory standards tighten, the Company believes there is increasing demand for scalable technologies that help ensure products are accurately...

Read more

CVS Health's Annual Impact in Connecticut

May 7, 2026 9:00 AM

Originally published in the CVS Health National Economic Impact Report With more than 9,000 locations and 300,000 employees, CVS Health is a driving force in the American economy, delivering $474 billion in economic impact nationwide. As one of the country's largest private employers, we're making health care more affordable and accessible for you and your family. Discover how our economic footprint benefits communities across the U.S: creating...

Read more

P-n-T Data Corp. Wins "Best Overall Healthcare Cybersecurity Solution" Designation in 2026 MedTech Breakthrough Awards

May 7, 2026 9:00 AM

P-n-T Data Corp., a provider of managed services for healthcare data sharing, today announced that it has been selected as winner of the "Best Overall Healthcare Cybersecurity Solution" award in the 10th annual MedTech Breakthrough Awards. The program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and...

Read more

Juniper Advisory Announces Three New Partners

May 7, 2026 9:00 AM

Juniper Advisory, a leading independent investment banking firm specializing in nonprofit hospital mergers and acquisitions, is pleased to announce the promotion of three Partners. As an employee-owned firm, Juniper remains committed to fostering a culture of experienced objectivity and alignment with client interests. The newly promoted partners include Brent McDonald, Farley Reardon and Casey Webb. Each brings decades of experience advising...

Read more

UNC Health Selects Evidently as its Clinical Data Intelligence Partner for an Enterprise Deployment Across Hospitals and Clinics in Triangle Region of North Carolina

May 7, 2026 8:00 AM

Evidently, the leading Clinical Data Intelligence company, today announced that UNC Health selected its platform for UNC Health hospitals and clinics in the Triangle Region of North Carolina. UNC Health's decision follows a 12-week pilot involving 100 users including clinicians, clinical documentation specialists and physician leaders. Pilot participants evaluated Evidently's effectiveness in synthesizing information from large and complex...

Read more

UniDoc to Update and Relaunch Legacy eHealth Systems with Pawnee Mental Health Services Across Rural Kansas

May 7, 2026 7:30 AM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") is pleased to announce that Pawnee Mental Health Services ("Pawnee"), a provider of mental health, substance use recovery and crisis services across 10 north central Kansas counties, has purchased UniDoc Connect software licenses to trial and relaunch eHealth equipment across its rural Kansas office network. Pawnee's account originated with AMD Telemedicine which...

Read more

Nurses Week Report: AI Documentation Must Reduce Charting Burden, Not Add Risk | Black Book Research

May 7, 2026 7:10 AM

In recognition of Nurses Week 2026, Black Book Research today released a new special report, "The Nurse Documentation and AI Readiness Gap," finding that registered nurses are open to artificial intelligence documentation support, but only if the technology reduces redundant charting, preserves nurse control, and does not shift legal or audit risk to bedside clinicians. The vendor-agnostic report is based on a survey of 118 registered nurse...

Read more

Beyond Function: Eydology Redefines Professional Identity with High-Style, Affordable Prescription Glasses for the Hybrid Work Era

May 7, 2026 2:25 AM

For many professionals in 2026, the workday begins on a screen-but rarely ends there. A morning Zoom call can quickly be followed by a client meeting across town, a midday coffee run, and an evening networking event. As hybrid work continues to reshape professional environments, affordable prescription glasses are evolving beyond a basic necessity into a visible extension of personal and professional identity. Eyewear brand EYDOLOGY is...

Read more